Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis

CONTEXT: Body mass index (BMI) is a useful tool for measuring body composition. It is unclear whether high BMI is a favourable indicator in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICIs). OBJECTIVE: To investigate the prognostic significance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Takemura, Kosuke, Yonekura, Satoru, Downey, Laura E., Evangelopoulos, Dimitris, Heng, Daniel Y.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Kidney Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068728/
https://www.ncbi.nlm.nih.gov/pubmed/35528786
http://dx.doi.org/10.1016/j.euros.2022.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068728/
https://www.ncbi.nlm.nih.gov/pubmed/35528786
http://dx.doi.org/10.1016/j.euros.2022.03.002

Ejemplares similares